Charles River Laboratories | Actif À Court Terme



Current Assets Changement Date
Agilent USD 4.11B 148M 2025-01
Align Technology USD 2.49B 104.95M 2024-12
Bio-Rad Laboratories USD 3.03B 25.32M 2024-12
Bruker USD 2.06B 133.1M 2024-12
Cardinal Health USD 35.76B 2.85B 2024-12
Charles River Laboratories USD 1.4B 91.65M 2024-12
Cigna USD 48.87B 352M 2024-12
CVS Health USD 68.65B 1.3B 2024-12
Danaher USD 9.5B 563M 2024-12
Dentsply International USD 1.75B 175M 2024-12
Elevance Health 58.73B 4.12B 2024-12
Galapagos EUR 3.34B 219.98M 2024-12
Hologic USD 3.49B 329.7M 2024-12
Humana USD 29.82B 3.11B 2024-12
Illumina USD 2.75B 373M 2024-12
Incyte USD 3.24B 430.32M 2024-12
IQVIA Holdings USD 5.83B 197M 2024-12
Laboratory Of America USD 4.81B 103.4M 2024-12
Lonza CHF 5.44B 113M 2024-12
McKesson USD 51.74B 1.6B 2024-12
Merck EUR 13.45B 479M 2024-12
Mettler Toledo International USD 1.19B 4.33M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Quest Diagnostics USD 2.39B 231M 2024-12
Revvity USD 2.35B 98.8M 2024-12
Thermo Fisher Scientific USD 22.14B 1.65B 2024-12
United Therapeutics USD 3.87B 126.5M 2024-12
UnitedHealth 85.78B 6.48B 2024-12
Walgreens Boots Alliance USD 16.24B 1.24B 2025-02
Waters USD 1.67B 21.39M 2024-12
West Pharmaceutical Services USD 1.54B 12.5M 2024-12



Charles River Laboratories Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.